Could a common compound help fight COVID-19 and flu? small study explores
NCT ID NCT07254052
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This small pilot study tested whether a sustained-release ammonium chloride formula (with vitamin D) can reduce virus levels in adults with mild or moderate COVID-19 or influenza. 32 participants took either the active formula or a vitamin D-only control twice daily for 10 days. Researchers measured viral load changes and tracked symptoms, hospitalizations, and other outcomes to gather early evidence on this potential add-on treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA A AND B are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
En Ygeia Clinic
Athens, 11524, Greece
-
Sotiria General Hospital
Athens, Greece
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Placenta cells tested as COVID fighter – but trial stopped early
- Plasma from COVID-19 survivors tested as treatment for the critically ill
- New bird flu booster shot shows promise in early trial
- Massive dengue drug trial aims to stop deadly progression
- 10,000 people tested: Cambodia's massive disease hunt begins